Boston Scientific Corporation
BSX Healthcare Medical Devices
Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024.
- Revenue
- +1.44%
- EPS
- −21.6%
- Free cash flow
- −25.3%
- Total debt
- +3.04%
Quarter to September 2026, against a year earlier
Follow BSX
Alert me
Boston Scientific Corporation (BSX) P/E ratio
As of 5 November 2026, Boston Scientific Corporation (BSX) trades at a P/E ratio of 18.7×. Over the past ten years it has ranged from 0.0× (March 2021) to 442× (April 2021); the current reading is higher than 21% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 48.6× | (31.37%) |
| FY2024 | 70.9× | 31.14% |
| FY2023 | 54.1× | (47.13%) |
| FY2022 | 102× | 66.07% |
| FY2021 | 61.6× | — |
| FY2020 | 0.0× | — |
| FY2019 | 13.4× | (54.19%) |
| FY2018 | 29.2× | (90.76%) |
| FY2017 | 316× | 275.50% |
| FY2016 | 84.2× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 18.4× | 7.02% |
| Jun 2026 | 17.2× | (34.18%) |
| Mar 2026 | 26.1× | (46.26%) |
| Dec 2025 | 48.6× | (5.82%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 17.5× |
| BSX Boston Scientific Corporation | 18.7× |
| MDT Medtronic PLC compare | 25.6× |
| PHG Koninklijke Philips N.V. compare | 25.8× |
| STE STERIS plc compare | 30.0× |
| DXCM DexCom, Inc. compare | 32.6× |
| SYK Stryker Corporation compare | 35.3× |
| ABT Abbott Laboratories compare | 42.3× |
| EW Edwards Lifesciences Corporation compare | 56.7× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on BSX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement